Article Sidebar
Views PDF: 80
KẾT QUẢ ĐIỀU TRỊ VIÊM TỤY CẤP DO TĂNG TRIGLYCERIDE
Main Article Content
Abstract
Summary:
Background: Treatment for hypertriglyceridemia-induced acute pancreatitis, in addition to emergency treatment methods such as conventional acute pancreatitis, requires methods to lower blood triglycerides.
Aim: Evaluate the outcome of treatment for hypertriglyceridemia-induced acute pancreatitis.
Objects and methods: Study of 95 patients of hypertriglyceridemia induced acute pancreatitis at Military Hospital 103 from January 2021 to October 2023. Patients were randomized into two groups: the intravenous insulin hypotriglyceridemia (ITTM) group and the plasma exchange (PEX) group. Data processing was done with SPSS 22.0 software.
Results: The PEX group was 22.1%; the intravenous insulin group was 77.89%. Other measures include: respiratory resuscitation was 6.31%, cardiovascular resuscitation was 7.36%, abdominal fluid drainage was 66.31%, surgery was 5.26%. The average treatment day was 9.7 ± 6.67 days, complications was 8.42%. The treatment of good results was 62.10%, medium was 34.74% and poor was 3.16%. Comparison of triglyceride lowering results between the two groups PEX and ITTM were the same with p > 0.05, the treatment results between the two groups ware not different with p > 0.05.
Conclusions:
Treatment of acute pancreatitis due to increased triglyceride with intravenous insulin infusion is safe and gives similar results to plasma conversion, but a large sample size study is needed to evaluate the effectiveness of the method.
Article Details
Keywords
Acute pancreatitis, Hypertriglyceridemia, insulin, plasma exchange, Hypertriglyceridemia, insulin, plasma exchange
References
2. Yang AL and McNabb-Baltar J. Hypertriglyceridemia and acute pancreatitis. Pancreatology. 2020; 20(5):795-800.
3. Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019; 14:27.
4. Song X, Shi D, Cui Q et al. Intensive insulin therapy versus plasmapheresis in the management of hypertriglyceridemia-induced acute pancreatitis (Bi-TPAI trial): Study protocol for a randomized controlled trial. Trials. 2019; 20(365):1-5.
5. Yu S, Yao D, Liang X, et al. Effects of different triglyceride-lowering therapies in patients with hypertriglyceridemia-induced acute pancreatitis. Experimental and Therapeutic Medicine. 2020; 19:2427-2432.
6. Banks PA, et al. Classification of acute pancreatitis - 2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 2013; 62(1): 102-111.
7. Tamez-Pérez HE, Sáenz-Gallegos R, et al. Insulin therapy in patients with severe hypertriglyceridemia. Rev Med Inst Mex Seguro Soc. 2006; 44(3):235-7.
8. Navina S, Chathur Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med. 2011; 3(107):1-26.
9. Jin M, Peng JM, Zhu HD, et al. Continuous intravenous infusion of insulin and heparin vs plasma exchange in hypertriglyceridemia-induced acute pancreatitis. J Dig Dis. 2018; 19(12): 766-772.
10. Nguyễn Gia Bình và CS. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và điều trị viêm tụy cấp tăng triglyceride. Bệnh viện Bạch Mai. 2013; Bộ Y tế.
11. Asencio CM, and Fleiszig ZB. Intra-abdominal hypertension: A systemic complication of severe acute pancreatitis. Medicina. 2022; 58(785):1-10.
12. Malbrain ML, De Laet IE, et al. Intraabdominal hypertension: Definitions, monitoring, interpretation and management. Best pract res clin anaesthesiol. 2013; 27(2):249-270.